These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 36611948)

  • 1. Delivery of CRISPR/Cas9 Plasmid DNA by Hyperbranched Polymeric Nanoparticles Enables Efficient Gene Editing.
    Xiu K; Saunders L; Wen L; Ruan J; Dong R; Song J; Yang D; Zhang J; Xu J; Chen YE; Ma PX
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic Polymer-Mediated CRISPR/Cas9 Plasmid Delivery for Genome Editing.
    Zhang Z; Wan T; Chen Y; Chen Y; Sun H; Cao T; Songyang Z; Tang G; Wu C; Ping Y; Xu FJ; Huang J
    Macromol Rapid Commun; 2019 Mar; 40(5):e1800068. PubMed ID: 29708298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of CRISPR/Cas9 for therapeutic genome editing.
    Xu X; Wan T; Xin H; Li D; Pan H; Wu J; Ping Y
    J Gene Med; 2019 Jul; 21(7):e3107. PubMed ID: 31237055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
    Wilbie D; Walther J; Mastrobattista E
    Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-efficient delivery of CRISPR/Cas9 using ionic liquid conjugated polymers for genome editing-based tumor therapy.
    Huang Z; Yang T; Yu J; Gao Y; Weng Y; Huang Y; Li S
    Biomater Sci; 2024 Mar; 12(7):1716-1725. PubMed ID: 38344762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Therapeutics.
    Givens BE; Naguib YW; Geary SM; Devor EJ; Salem AK
    AAPS J; 2018 Oct; 20(6):108. PubMed ID: 30306365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylenimine based magnetic nanoparticles mediated non-viral CRISPR/Cas9 system for genome editing.
    Rohiwal SS; Dvorakova N; Klima J; Vaskovicova M; Senigl F; Slouf M; Pavlova E; Stepanek P; Babuka D; Benes H; Ellederova Z; Stieger K
    Sci Rep; 2020 Mar; 10(1):4619. PubMed ID: 32165679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced delivery of CRISPR/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy.
    Wu K; He M; Mao B; Xing Y; Wei S; Jiang D; Wang S; Alkuhali AA; Guo J; Gan Z; Li M; Li X; Chen H
    J Control Release; 2024 Oct; 374():293-311. PubMed ID: 39151831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized PDA/DEX-PEI@HA nanoparticles combined with sleeping-beauty transposons for multistage targeted delivery of CRISPR/Cas9 gene.
    Ma K; Li W; Zhu G; Sun S; Chi H; Yin Y; Diao H; Xing XJ; Guo Z; Wang L; Xu W; Cui C; Xu J
    Biomed Pharmacother; 2021 Oct; 142():112061. PubMed ID: 34449313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
    Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
    Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells.
    Moradi P; Hasanzadeh A; Radmanesh F; Rajai Daryasarei S; Hosseini ES; Kiani J; Shahbazi A; Nourizadeh H; Eslami M; Dorgalaleh A; Sahlolbei M; Hamblin MR; Karimi M
    Nanotechnology; 2021 Nov; 33(7):. PubMed ID: 34727527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric micellar nanoparticles for effective CRISPR/Cas9 genome editing in cancer.
    Li Y; Li C; Yan J; Liao Y; Qin C; Wang L; Huang Y; Yang C; Wang J; Ding X; Yang YY; Yuan P
    Biomaterials; 2024 Sep; 309():122573. PubMed ID: 38677222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A CRISPR/Cas9 based polymeric nanoparticles to treat/inhibit microbial infections.
    Verma R; Sahu R; Singh DD; Egbo TE
    Semin Cell Dev Biol; 2019 Dec; 96():44-52. PubMed ID: 30986568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
    Li S; Du M; Deng J; Deng G; Li J; Song Z; Han H
    Acta Biomater; 2022 Dec; 154():597-607. PubMed ID: 36243370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.
    Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN
    Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducible Branched Ester-Amine Quadpolymers (rBEAQs) Codelivering Plasmid DNA and RNA Oligonucleotides Enable CRISPR/Cas9 Genome Editing.
    Rui Y; Wilson DR; Sanders K; Green JJ
    ACS Appl Mater Interfaces; 2019 Mar; 11(11):10472-10480. PubMed ID: 30794383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Key considerations in designing CRISPR/Cas9-carrying nanoparticles for therapeutic genome editing.
    Xu Y; Liu R; Dai Z
    Nanoscale; 2020 Oct; 12(41):21001-21014. PubMed ID: 33078813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Versatile Redox-Responsive Polyplexes for the Delivery of Plasmid DNA, Messenger RNA, and CRISPR-Cas9 Genome-Editing Machinery.
    Wang Y; Ma B; Abdeen AA; Chen G; Xie R; Saha K; Gong S
    ACS Appl Mater Interfaces; 2018 Sep; 10(38):31915-31927. PubMed ID: 30222305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide.
    Wang HX; Song Z; Lao YH; Xu X; Gong J; Cheng D; Chakraborty S; Park JS; Li M; Huang D; Yin L; Cheng J; Leong KW
    Proc Natl Acad Sci U S A; 2018 May; 115(19):4903-4908. PubMed ID: 29686087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.